Vensana Capital — 2022 Investments
3 investments dated 2022 · listed companies and verified rows first · show all
Nyra Medical develops the CARLEN (Cardiac Leaflet Enhancer) system, a transcatheter single-leaflet device for repairing functional mitral regurgitation while preserving native valve function.
BiotechHealthtechMedical DevicesAtlanta, US
Dr. Murali Padala(Founder)Dr. Eric Sarin(Founder, Director)Dr. Kirthana Suresh(Founder)Sai Muralidhar Padala(Executive Officer, Director)Lori Chmura(CEO)inGowri Raman(Director)
Co-investorsBroadview VenturesEpidarex CapitalGRA Venture
Monteris develops minimally invasive laser ablation technology (LITT) used to treat brain conditions including oncology tumors and drug-resistant epilepsy.
BiotechHealthtechMedical DevicesPlymouth, US
JAMES ERICKSON(Executive Officer)inMARTIN EMERSON(Executive Officer, Director)John Schellhorn(Executive Officer, Director, Promoter)inRobert K Davidson(Executive Officer)
BoardRICHARD EMMITT(Director)inGregory Barrett(Director)
Board seatKirk NielsenBill Hoffman· per SEC Form D · $13.7M raise · filed Sep 2022
Co-investorsThe Vertical Group
Moxe operates a platform for the secure exchange of clinical data between healthcare payers and providers, transforming that data into usable formats to support payment and operations use cases.
Data & InfrastructureDigital HealthHealthtechMadison, US
Daniel Wilson(Executive Officer, Director)
BoardGary J. Kurtzman, M.D.(Director)
Co-investorsGreat Oaks Venture CapitalApolloTrinity CapitalUPMC Enterprises
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.












